TASHA CROSSNO: Open Payments
NPI 1730892811 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 39 payments from 20 companies in 2025. Trend: 2023 $229 · 2024 $0 · 2025 $2,358
Travel & lodging: $1,325Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 4 | $1,626 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Merz Pharmaceuticals, LLC | 2 | $61 |
| Genentech USA, Inc. | 3 | $53 |
| Amgen Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $47 |
| ABBVIE INC. | 2 | $46 |
| PFIZER INC. | 3 | $45 |
| Alexion Pharmaceuticals, Inc. | 2 | $42 |
Products named: VNS Therapy, INGREZZA, Symbravo, Xeomin, Ocrevus Zunovo, VYEPTI, NURTEC ODT, ULTOMIRIS.
Industry payments across AR — which companies pay providers there.
